1,2,3,4-Tetrahydro-5-iodo-1,3,6-trimethyl-2,4-dioxopyrimidine is a heterocyclic organic compound characterized by its pyrimidine ring structure, which is a six-membered ring containing two nitrogen atoms at positions 1 and 3. The presence of the tetrahydro group indicates that the compound has undergone partial saturation, contributing to its stability and reactivity. The iodine atom at position 5 introduces a halogen, which can influence the compound's reactivity and potential applications in medicinal chemistry. The trimethyl groups at positions 1, 3, and 6 suggest that the compound has significant steric hindrance, which may affect its interactions with biological targets. The dioxo functional groups at positions 2 and 4 indicate the presence of carbonyl functionalities, which can participate in various chemical reactions, including nucleophilic attacks. Overall, this compound may exhibit interesting pharmacological properties, making it a candidate for further research in drug development and synthesis.

1,2,3,4-TETRAHYDRO-5-IODO-1,3,6-TRIMETHYL-2,4-DIOXOPYRIMIDINE

134039-54-6: 1,2,3,4-Tetrahydro-5-iodo-1,3,6-trimethyl-2,4-dioxopyrimidine is a heterocyclic organic compound characterized by its pyrimidine ring structure, which is a six-membered ring containing two nitrogen atoms at positions 1 and 3. The presence of the tetrahydro group indicates that the compound has undergone partial saturation, contributing to its stability and reactivity. The iodine atom at position 5 introduces a halogen, which can influence the compound's reactivity and potential applications in medicinal chemistry. The trimethyl groups at positions 1, 3, and 6 suggest that the compound has significant steric hindrance, which may affect its interactions with biological targets. The dioxo functional groups at positions 2 and 4 indicate the presence of carbonyl functionalities, which can participate in various chemical reactions, including nucleophilic attacks. Overall, this compound may exhibit interesting pharmacological properties, making it a candidate for further research in drug development and synthesis.

CAS 134039-54-6

1,2,3,4-TETRAHYDRO-5-IODO-1,3,6-TRIMETHYL-2,4-DIOXOPYRIMIDINE

5-Iodo-1,3,6-trimethyluracil

Ref: 54-OR30509